Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Bryonia cretica
Végétal grimpant de la région européenne, utilisé traditionnellement pour les arthritides.
Bryonia dioica (Bryonia cretica) is a toxic European climbing herb used exclusively in homeopathic preparations for anti-inflammatory and analgesic effects. Its primary active compounds include bryonin, bryonidin, and cucurbitacins, which contribute to its traditional use in treating arthritis and pleurisy. Modern research is limited (Evidence Level C) and focuses on its anti-inflammatory properties.
Cucurbitacins in Bryonia inhibit cyclooxygenase (COX) and lipoxygenase (LOX) pathways, reducing prostaglandin and leukotriene synthesis, which underlies its anti-inflammatory activity. Bryonin and bryonidin may modulate NF-κB signaling, decreasing pro-inflammatory cytokine release. In homeopathic dilutions, these compounds are present at sub-pharmacological levels, and mechanisms remain unclear, possibly involving hormesis or placebo effects.
Végétal grimpant de la région européenne, utilisé traditionnellement pour les arthritides.
Bryonia dioica (Bryonia cretica) is a toxic European climbing herb used exclusively in homeopathic preparations for anti-inflammatory and analgesic effects. Its primary active compounds include bryonin, bryonidin, and cucurbitacins, which contribute to its traditional use in treating arthritis and pleurisy. Modern research is limited (Evidence Level C) and focuses on its anti-inflammatory properties.
Cucurbitacins in Bryonia inhibit cyclooxygenase (COX) and lipoxygenase (LOX) pathways, reducing prostaglandin and leukotriene synthesis, which underlies its anti-inflammatory activity. Bryonin and bryonidin may modulate NF-κB signaling, decreasing pro-inflammatory cytokine release. In homeopathic dilutions, these compounds are present at sub-pharmacological levels, and mechanisms remain unclear, possibly involving hormesis or placebo effects.